Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 445 to 448 of 448 entries
Sorted by: Best Match Show Resources per page
Patient Safety during ECMO Transportation: Single Center Experience and Literature Review.

Emergency medicine international

Puslecki M, Baumgart K, Ligowski M, Dabrowski M, Stefaniak S, Ladzinska M, Goszczynska E, Marcinkowski P, Olasinska-Wisniewska A, Klosiewicz T, Pawlak A, Zielinski M, Puslecki L, Podlewski R, Szarpak L, Jemielity M, Perek B.
PMID: 33688436
Emerg Med Int. 2021 Feb 22;2021:6633208. doi: 10.1155/2021/6633208. eCollection 2021.

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has been proven to support in lifesaving rescue therapy. The best outcomes can be achieved in high-volume ECMO centers with dedicated emergency transport teams.AIM: The aim of this study was to analyze the safety...

Cite
Puslecki M, Baumgart K, Ligowski M, et al. Patient Safety during ECMO Transportation: Single Center Experience and Literature Review. Emerg Med Int. 2021;2021:6633208doi: 10.1155/2021/6633208.
Puslecki, M., Baumgart, K., Ligowski, M., Dabrowski, M., Stefaniak, S., Ladzinska, M., Goszczynska, E., Marcinkowski, P., Olasinska-Wisniewska, A., Klosiewicz, T., Pawlak, A., Zielinski, M., Puslecki, L., Podlewski, R., Szarpak, L., Jemielity, M., & Perek, B. (2021). Patient Safety during ECMO Transportation: Single Center Experience and Literature Review. Emergency medicine international, 20216633208. https://doi.org/10.1155/2021/6633208
Puslecki, Mateusz, et al. "Patient Safety during ECMO Transportation: Single Center Experience and Literature Review." Emergency medicine international vol. 2021 (2021): 6633208. doi: https://doi.org/10.1155/2021/6633208
Puslecki M, Baumgart K, Ligowski M, Dabrowski M, Stefaniak S, Ladzinska M, Goszczynska E, Marcinkowski P, Olasinska-Wisniewska A, Klosiewicz T, Pawlak A, Zielinski M, Puslecki L, Podlewski R, Szarpak L, Jemielity M, Perek B. Patient Safety during ECMO Transportation: Single Center Experience and Literature Review. Emerg Med Int. 2021 Feb 22;2021:6633208. doi: 10.1155/2021/6633208. eCollection 2021. PMID: 33688436; PMCID: PMC7920709.
Copy Download .nbib Format: NLM
Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder.

Psychopharmacology

Martens MAG, Filippini N, Harmer CJ, Godlewska BR.
PMID: 34477887
Psychopharmacology (Berl). 2021 Sep 03; doi: 10.1007/s00213-021-05915-7. Epub 2021 Sep 03.

RATIONAL: With no available response biomarkers, matching an appropriate antidepressant to an individual can be a lengthy process. Improving understanding of processes underlying treatment responsivity in depression is crucial for facilitating work on response biomarkers.OBJECTIVES: To identify differences in...

Cite
Martens MAG, Filippini N, Harmer CJ, et al. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacology (Berl). 2021;doi: 10.1007/s00213-021-05915-7.
Martens, M. A. G., Filippini, N., Harmer, C. J., & Godlewska, B. R. (2021). Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacology, . https://doi.org/10.1007/s00213-021-05915-7
Martens, Marieke A G, et al. "Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder." Psychopharmacology vol. (2021). doi: https://doi.org/10.1007/s00213-021-05915-7
Martens MAG, Filippini N, Harmer CJ, Godlewska BR. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacology (Berl). 2021 Sep 03; doi: 10.1007/s00213-021-05915-7. Epub 2021 Sep 03. PMID: 34477887.
Copy Download .nbib Format: NLM
Investigations of Structural and Electrical Properties of ALD Films Formed with the Ozone Precursor.

Materials (Basel, Switzerland)

Seweryn A, Lawniczak-Jablonska K, Kuzmiuk P, Gieraltowska S, Godlewski M, Mroczynski R.
PMID: 34576619
Materials (Basel). 2021 Sep 18;14(18). doi: 10.3390/ma14185395.

The continuous development of ALD thin films demands ongoing improvements and changes toward fabricating materials with tailored properties that are suitable for different practical applications. Ozone has been recently established as a precursor, with distinct advantages over the alternative...

Cite
Seweryn A, Lawniczak-Jablonska K, Kuzmiuk P, et al. Investigations of Structural and Electrical Properties of ALD Films Formed with the Ozone Precursor. Materials (Basel). 2021;14(18)doi: 10.3390/ma14185395.
Seweryn, A., Lawniczak-Jablonska, K., Kuzmiuk, P., Gieraltowska, S., Godlewski, M., & Mroczynski, R. (2021). Investigations of Structural and Electrical Properties of ALD Films Formed with the Ozone Precursor. Materials (Basel, Switzerland), 14(18), . https://doi.org/10.3390/ma14185395
Seweryn, Aleksandra, et al. "Investigations of Structural and Electrical Properties of ALD Films Formed with the Ozone Precursor." Materials (Basel, Switzerland) vol. 14,18 (2021). doi: https://doi.org/10.3390/ma14185395
Seweryn A, Lawniczak-Jablonska K, Kuzmiuk P, Gieraltowska S, Godlewski M, Mroczynski R. Investigations of Structural and Electrical Properties of ALD Films Formed with the Ozone Precursor. Materials (Basel). 2021 Sep 18;14(18). doi: 10.3390/ma14185395. PMID: 34576619; PMCID: PMC8470079.
Copy Download .nbib Format: NLM
Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla.

Psychopharmacology

Godlewska BR, Williams S, Emir UE, Chen C, Sharpley AL, Goncalves AJ, Andersson MI, Clarke W, Angus B, Cowen PJ.
PMID: 34609538
Psychopharmacology (Berl). 2021 Oct 05; doi: 10.1007/s00213-021-05986-6. Epub 2021 Oct 05.

RATIONALE: Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables...

Cite
Godlewska BR, Williams S, Emir UE, et al. Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla. Psychopharmacology (Berl). 2021;doi: 10.1007/s00213-021-05986-6.
Godlewska, B. R., Williams, S., Emir, U. E., Chen, C., Sharpley, A. L., Goncalves, A. J., Andersson, M. I., Clarke, W., Angus, B., & Cowen, P. J. (2021). Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla. Psychopharmacology, . https://doi.org/10.1007/s00213-021-05986-6
Godlewska, Beata R, et al. "Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla." Psychopharmacology vol. (2021). doi: https://doi.org/10.1007/s00213-021-05986-6
Godlewska BR, Williams S, Emir UE, Chen C, Sharpley AL, Goncalves AJ, Andersson MI, Clarke W, Angus B, Cowen PJ. Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla. Psychopharmacology (Berl). 2021 Oct 05; doi: 10.1007/s00213-021-05986-6. Epub 2021 Oct 05. PMID: 34609538.
Copy Download .nbib Format: NLM
Showing 445 to 448 of 448 entries